Tested Applications
| Positive IHC detected in | human ovary tumor tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
Biotin-66467 targets Heavy chain of Rabbit IgG in IHC applications and shows reactivity with rabbit samples.
| Tested Reactivity | rabbit |
| Host / Isotype | Mouse / IgG1 |
| Class | Monoclonal |
| Type | Antibody |
| Immunogen |
Protein Predict reactive species |
| Full Name | Heavy chain of Rabbit IgG |
| Gene Symbol | |
| Gene ID (NCBI) | |
| RRID | AB_2883072 |
| Conjugate | Biotin |
| Form | Liquid |
| Purification Method | Protein G purification |
| UNIPROT ID | N/A |
| Storage Buffer | PBS with 50% glycerol, 0.05% Proclin300, 0.5% BSA, pH 7.3. |
| Storage Conditions | Store at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
Background Information
This antibody specifically recognizes the heavy chain of Rabbit IgG.
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for Biotin Heavy chain of Rabbit IgG antibody Biotin-66467 | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The Heavy chain of Rabbit IgG Monoclonal antibody (catalog 66467-1-Ig, Biotin conjugate) has 15 citations, spanning journals including Adv Sci, Pharmacol Res, Sci Total Environ, Communications Biology, Cancer Biol Ther, European Journal of Immunology, Journal of Translational Autoimmunology, J Biochem Mol Toxicol, Genomics, Cell Biochem Funct, Exp Ther Med, Oncol Lett, Transl Cancer Res, and PNAS. Research fields include photoreceptor ciliary/retinal biology, melanoma immunotherapy, hepatocyte iron metabolism, neuropsychiatric lupus and neuroimmunology, prostate and bladder cancer, renal PLA2R1 model studies, and cervical, glioma, gastric, and ovarian cancers, using IP, CoIP, IF, WB, and IHC.
| Species | Application | Title |
|---|---|---|
Cancer Biol Ther EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/β-catenin signaling pathway. | ||
Exp Ther Med CLCA2 suppresses the proliferation, migration and invasion of cervical cancer. |



